Mesothelioma Breaking News Archives | Surviving Mesothelioma

Antibody-Drug Conjugate Fails to Stop Recurrent Pleural Mesothelioma

A new drug designed to treat recurrent malignant mesothelioma while minimizing side effects has failed to meet expectations. Anetumab ravtansine, is an antibody-drug conjugate (ADC) developed with biotechnology firms ImmunoGen and MorphoSys and owned by Bayer.  It had been the focus of a Phase II clinical trial for pleural mesothelioma. The trial has now been stopped. Understanding ADCs Many of the most dangerous side effects of … Continue reading Antibody-Drug Conjugate Fails to Stop Recurrent Pleural Mesothelioma »

Mesothelioma Awareness Day Gets a Boost from Social Media

    Victims of mesothelioma and their families are being invited to make their voices and their stories heard on social media in advance of the 11th annual Mesothelioma Awareness Day on September 26th. The invitation is being extended by the Asbestos Disease Awareness Organization (ADAO), an organization committed to ending the scourge of asbestos diseases like mesothelioma through education, advocacy and community. Founded in … Continue reading Mesothelioma Awareness Day Gets a Boost from Social Media »

European Group Issues Updated Treatment Guidelines for Mesothelioma

physician and colleagues

A group of medical researchers has just released an updated set of clinical practice guidelines for treating patients with malignant pleural mesothelioma, one of the rarest and most treatment-resistant forms of cancer. The guidelines, released by the European Society for Medical Oncology and published in the newest issue of the Annals of Oncology, contain six sets of recommendations designed to support clinicians in the management … Continue reading European Group Issues Updated Treatment Guidelines for Mesothelioma »

Skin Cancer Drug Produces Exceptional Results in New Mesothelioma Trial

Respiratory Disease

A drug approved to treat skin cancer has produced what researchers are calling “unprecedented” control of malignant pleural mesothelioma. As announced at the annual meeting of the American Association for Cancer Research which met in Philadelphia in April, pembrolizumab either stopped tumor growth or even reversed it in more than three quarters of the mesothelioma patients tested. Pembrolizumab (brand name Keytruda) is a monoclonal antibody … Continue reading Skin Cancer Drug Produces Exceptional Results in New Mesothelioma Trial »

Mesothelioma Vaccine Receives Orphan Drug Approval

woman mesothelioma doctor holds syringe

Mesothelioma patients who are not candidates for surgery may soon have another treatment option. The FDA has granted orphan drug approval to a new cancer vaccine called CRS-207. CRS-207 is manufactured by Aduro Biotech, Inc. and is made from an attenuated (less potent) version of the bacteria Listeria monocytogenes. CRS-207 triggers a powerful immune response against cells that produce mesothelin, a tumor-associated antigen produced by … Continue reading Mesothelioma Vaccine Receives Orphan Drug Approval »

Multi-Center Study Reveals “Genomic Basis” of Mesothelioma

S Doctors with the Broad Institute of Harvard and MIT, the University of Hawaii Cancer Center, and the Departments of Cardiothoracic Surgery and Genome Technology at New York’s Langone Medical Center, have identified four specific genes they believe are directly linked to mesothelioma development. Scientists have long known that asbestos in the tissue can trigger genetic mutations that lead to mesothelioma. But, while past studies … Continue reading Multi-Center Study Reveals “Genomic Basis” of Mesothelioma »

New Mesothelioma Treatment Boosts Chemotherapy Response

An important new study from one of the country’s top mesothelioma research labs has found a way to significantly boost the impact of chemotherapy on mesothelioma patients who are not eligible for surgery. Dr. Raffit Hassan and his colleagues at the National Cancer Institute have been focusing their efforts on an immunotoxin – a potent toxin inked to an antibody – to selectively target mesothelioma … Continue reading New Mesothelioma Treatment Boosts Chemotherapy Response »

Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul … Continue reading Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers »

Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural … Continue reading Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma »

Get your free copy of
“Surviving Mesothelioma” Today!